Find out why AstraZeneca is pulling its COVID-19 vaccine and the impact it's having on the global market. 🌍💉
AstraZeneca has made a bold move by initiating the worldwide withdrawal of its COVID-19 vaccine, Vaxzevria. The pharmaceutical giant cited a surplus of other available vaccines and declining demand as the primary reasons behind this decision. This withdrawal comes after facing safety concerns related to rare blood clots, prompting various countries to temporarily halt the use of the AstraZeneca vaccine.
The Anglo-Swedish drugmaker expressed its pride in the success of the vaccine, which initially received approval in January 2021. With over three billion doses administered, AstraZeneca is now facing the challenge of reduced demand amidst the availability of newer and more favored vaccine options in the market.
In response to the withdrawal, the European Medicines Agency has pulled the authorization for AstraZeneca's COVID-19 vaccine in Europe. This decision aligns with AstraZeneca's global strategy to address the waning demand for their vaccine and focus on the evolving needs of the pandemic.
Overall, AstraZeneca's decision reflects the shifting landscape of the vaccine market and the competitive dynamics among different COVID-19 vaccine manufacturers. The withdrawal of the AstraZeneca vaccine raises questions about the future of vaccination strategies and the role of early vaccine pioneers in the ongoing fight against the pandemic.
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a 'surplus of available updated vaccines' since the ...
AstraZeneca says a surplus of other available COVID-19 vaccines and declining demand are the reasons behind why it's withdrawing Vaxzevria.
Le géant pharmaceutique britannique Astrazeneca a annoncé mercredi qu'il retirait de la vente son vaccin contre la Covid-19 Vaxzevria.
AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in ...
The vaccine, initially approved in January 2021, faced safety concerns over rare blood clots, prompting various countries to halt its use temporarily.
Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab.
After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, ...
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled.
Le géant pharmaceutique AstraZeneca a demandé le retrait de l'autorisation européenne pour son vaccin contre la Covid-19, selon le régulateur européen des ...
Le groupe anglo-suédois AstraZeneca a cessé la production de son vaccin anti-covid. Officiellement parce que les ventes ont chuté. Le laboratoire est aussi ...
Le vaccin Vaxzevria AstraZeneca a été l'un des premiers vaccins sur le marché pendant la pandémie. Photo : Getty Images / LOUAI BESHARA. Agence France-Presse.
AstraZeneca is withdrawing its Oxford-collaborated Covid-19 vaccine from global markets, the UK-based pharma company confirmed in a statement to Endpoints ...
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.
Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, ...
The marketing authorization for the vaccine, Vaxzevria, in the European Union was withdrawn at the company's request this week as the vaccine is no longer ...
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
Plus de trois milliards de doses du Vaxzevria ont été distribuées dans le monde, selon la pharmaceutique britannique.
Le groupe fait état d'un « surplus de vaccins mis à jour » face aux différents variants du virus, et un « déclin de la demande pour le Vaxzevria, ...
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
A noter que les vaccins ARN sont ceux de Pfizer et Moderna, qui "vont persister sur le marché", ajoute le professeur. De son côté, le Dr Moulay Saïd Afif, ...
AstraZeneca said as multiple vaccines against newer variants of the pandemic coronavirus have been developed, there is a surplus. Demand for Vaxzevria declined ...
Le vaccin contre le Covid-19 du géant pharmaceutique AstraZeneca a été retiré de la vente, mardi 7 mai, notamment, face au « déclin de la demande ».
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
AstraZeneca's COVID-19 vaccine was first approved in Canada in Feb. 2021, and authorization for it was cancelled in Dec. 2023.
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines ...